TOBAM’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
|
|||||
|
2025
Q1 | $2.44M | Sell |
|
|||||
|
2024
Q4 | $4.27M | Sell |
|
|||||
|
2024
Q3 | $8.44M | Sell |
|
|||||
|
2024
Q2 | $12.5M | Sell |
|
|||||
|
2024
Q1 | $24.6M | Sell |
|
|||||
|
2023
Q4 | $29.9M | Sell |
|
|||||
|
2023
Q3 | $33.4M | Sell |
|
|||||
|
2023
Q2 | $29.4M | Sell |
|
|||||
|
2023
Q1 | $36.7M | Buy |
|
|||||
|
2022
Q4 | $34.4M | Buy |
|
|||||
|
2022
Q3 | $30.5M | Sell |
|
|||||
|
2022
Q2 | $29.9M | Buy |
|
|||||
|
2022
Q1 | $20.3M | Buy |
|
|||||
|
2021
Q4 | $16.3M | Buy |
|
|||||
|
2021
Q3 | $12M | Sell |
|
|||||
|
2021
Q2 | $12.2M | Buy |
|
|||||
|
2021
Q1 | $9.28M | Buy |
|
|||||
|
2020
Q4 | $5.77M | Buy |
|
|||||
|
2020
Q3 | $3.01M | Sell |
|
|||||
|
2020
Q2 | $6.67M | Sell |
|
|||||
|
2020
Q1 | $5.03M | Buy |
|
|||||
|
2019
Q4 | $2.34M | Buy |
|
|||||
|
2019
Q3 | $377K | Buy |
|
|||||
|
2019
Q2 | $308K | Buy |
|
|||||
|
2019
Q1 | $277K | Buy |
|
|||||
|
2018
Q4 | $126K | Buy |
|